Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer revision identifier advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. This prevents viewing the NCT03554473 study details and related navigation on ClinicalTrials.gov.SummaryDifference25%

- Check30 days agoChange DetectedRevision updated from v3.6.6 to v3.7.0, indicating a maintenance release of the page. This change seems to affect the underlying platform or user interface rather than the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe study page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be an administrative update to the record that does not change the study content.SummaryDifference0.0%

- Check65 days agoChange DetectedThe site revision label updated from v3.6.4 to v3.6.5, signaling a new deployment of the platform. There is no indication that the content of the study page was changed.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision label changed from v3.6.3 to v3.6.4. This reflects a deployment or maintenance update and does not alter the displayed content.SummaryDifference0.0%

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.